IRIS - Res&Arch Institutional Research Information System - Research & Archive

PASQUALUCCI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.748
AS - Asia 3.080
EU - Europa 2.614
SA - Sud America 459
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 9.974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.672
SG - Singapore 1.441
IE - Irlanda 483
UA - Ucraina 458
HK - Hong Kong 436
RU - Federazione Russa 382
IT - Italia 363
BR - Brasile 360
VN - Vietnam 334
CN - Cina 324
SE - Svezia 271
KR - Corea 187
DE - Germania 156
FR - Francia 154
FI - Finlandia 118
TR - Turchia 80
GB - Regno Unito 75
IN - India 66
AR - Argentina 38
CA - Canada 36
BD - Bangladesh 34
IQ - Iraq 32
PL - Polonia 27
MX - Messico 26
ZA - Sudafrica 21
AT - Austria 20
BE - Belgio 20
NL - Olanda 19
UZ - Uzbekistan 19
CH - Svizzera 18
EC - Ecuador 18
SA - Arabia Saudita 16
MA - Marocco 15
JP - Giappone 14
ES - Italia 13
PK - Pakistan 12
CO - Colombia 11
DZ - Algeria 10
ID - Indonesia 10
LB - Libano 10
GR - Grecia 9
PH - Filippine 9
VE - Venezuela 8
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
PY - Paraguay 6
GE - Georgia 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
CZ - Repubblica Ceca 4
IL - Israele 4
PA - Panama 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DO - Repubblica Dominicana 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
LT - Lituania 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 9.970
Salva come PNG Salva come JPEG
Città #
Singapore 1.056
San Jose 510
Dublin 483
Chandler 443
Hong Kong 436
Jacksonville 252
San Mateo 251
Ashburn 213
Boardman 203
Dong Ket 202
Seoul 186
Santa Clara 156
Moscow 149
Altamura 135
Perugia 135
Medford 116
Princeton 113
Lauterbourg 109
Ann Arbor 97
Lawrence 90
Wilmington 85
Andover 66
Beijing 59
Izmir 57
New York 46
Ho Chi Minh City 45
Des Moines 43
The Dalles 43
Los Angeles 38
Saint Petersburg 38
São Paulo 31
Hanoi 30
Piscataway 30
Norwalk 26
Helsinki 21
Nuremberg 21
Brussels 20
Falls Church 19
Frankfurt am Main 19
Dallas 18
Belo Horizonte 17
Woodbridge 17
Amelia 16
Munich 14
Orem 14
Stockholm 14
Tashkent 14
Tokyo 14
West Jordan 14
Chicago 13
Johannesburg 13
Montreal 13
Rio de Janeiro 13
Phoenix 12
San Paolo di Civitate 12
Warsaw 12
Shanghai 11
Baghdad 10
Chennai 10
Dearborn 10
Istanbul 10
Amsterdam 9
Brooklyn 9
Haiphong 9
Mexico City 9
Columbus 8
Denver 8
Hefei 8
Houston 8
London 8
Mumbai 8
Redwood City 8
Vienna 8
Casablanca 7
Guangzhou 7
Jeddah 7
Nanning 7
Porto Alegre 7
Rome 7
Baku 6
Den Haag 6
Dhaka 6
Redmond 6
Secaucus 6
Toronto 6
Algiers 5
Atlanta 5
Boston 5
Da Nang 5
Frankfurt Am Main 5
Guarulhos 5
Guayaquil 5
Jakarta 5
Jamaica 5
Medellín 5
Philadelphia 5
Quito 5
San Diego 5
San Francisco 5
Turku 5
Totale 6.616
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 172
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 149
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 145
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 140
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 139
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 139
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 139
AID is required for germinal center-derived lymphomagenesis. 128
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 127
Analysis of the coding genome of diffuse large B cell lymphoma 124
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 123
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 123
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 122
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 121
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 121
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 118
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 115
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 114
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 113
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 112
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 112
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 108
BRAF mutations in hairy-cell leukemia. 108
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 108
B-cell receptor signaling derailed in lymphomas. 107
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 107
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 106
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 105
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 104
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 104
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 103
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 101
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 101
Targeted antibodies in the treatment of lymphomas. 97
Expression of the AID protein in normal and neoplastic B cells. 96
Molecular pathogenesis of germinal center-derived B cell lymphomas 96
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 95
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 94
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 93
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 92
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 92
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 92
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 91
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 91
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 87
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 84
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 84
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 84
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 82
Follicular lymphoma dynamics 81
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 81
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 81
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 81
Repurposing Dasatinib for diffuse large B cell lymphoma. 78
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 77
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 77
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 77
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 77
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 76
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 76
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 76
The genetics of nodal marginal zone lymphoma 76
Molecular Biology of Lymphoma 76
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 75
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 75
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 74
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 73
Molecular Genetics of Lymphoma 72
Emerging epigenetic-modulating therapies in lymphoma 71
Genetics of diffuse large b-cell lymphoma 70
Dissecting KMT2D missense mutations in Kabuki syndrome patients 70
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 69
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 69
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 69
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 69
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 68
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 68
Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL 67
Molecular pathogenesis of diffuse large B-cell lymphoma 67
Genomic profiling for clinical decision making in lymphoid neoplasms 66
The germinal center in the pathogenesis of B cell lymphomas 66
Immunotoxin therapy of hematological malignancies. 65
Genetics of follicular lymphoma transformation. 64
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas 64
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 63
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 63
The genetic landscape of diffuse large B-cell lymphoma 63
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities 62
null 62
Molecular Biology of Lymphoma 62
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 61
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 61
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 61
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 60
Towards patient-based cancer therapeutics. 60
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 59
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 59
New approaches to lymphoma diagnosis. 58
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 57
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. 56
Totale 8.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021326 0 0 0 0 0 0 0 0 0 28 76 222
2021/2022961 24 180 14 61 43 11 14 291 16 35 124 148
2022/20231.607 125 313 23 144 98 170 1 72 604 5 41 11
2023/2024671 33 51 31 11 4 5 174 9 96 31 79 147
2024/20251.593 102 175 20 49 317 51 37 89 323 115 173 142
2025/20263.445 305 226 208 347 393 321 716 181 526 222 0 0
Totale 10.203